Isomorphic Labs
Isomorphic Labs Limited is a London-based drug discovery company, which uses artificial intelligence for drug discovery. Isomorphic Labs was incorporated on February 4, 2021 and announced on November 5, 2021. It was established under Alphabet Inc. as a spin-off from its AI research lab Deepmind. It is led by Demis Hassabis. The company draws upon Deepmind's AlphaFold 2 technology, which can be used to predict protein structures in the human body with high accuracy, allowing its researchers to find new target pathways for drug delivery. In December 2022, Isomorphic Labs announced its second office location in Lausanne, Switzerland. References

External links
 

Alphabet Inc.
Biotechnology companies
Drug discovery
AI companies
Companies based in London
2021 establishments in the United States